US 12,442,024 B2
Dihomo-gamma-linolenic acid-containing microbial oil/lipid with reduced arachidonic acid content
Seizo Sato, Tokyo (JP); Takayoshi Sekiguchi, Tokyo (JP); and Misaki Takahashi, Tokyo (JP)
Assigned to Nippon Suisan Kaisha, Ltd., Tokyo (JP)
Filed by Nippon Suisan Kaisha, Ltd., Tokyo (JP)
Filed on Jun. 28, 2021, as Appl. No. 17/359,948.
Application 17/359,948 is a continuation in part of application No. PCT/JP2019/051565, filed on Dec. 27, 2019.
Claims priority of application No. 2018-248464 (JP), filed on Dec. 28, 2018.
Prior Publication US 2021/0324433 A1, Oct. 21, 2021
Int. Cl. C12P 7/6418 (2022.01); A61K 31/202 (2006.01); A61K 45/06 (2006.01); C12N 1/14 (2006.01); C12N 9/02 (2006.01); C12R 1/645 (2006.01)
CPC C12P 7/6418 (2013.01) [A61K 31/202 (2013.01); A61K 45/06 (2013.01); C12N 1/145 (2021.05); C12N 9/0071 (2013.01); C12R 2001/645 (2021.05); C12Y 114/19003 (2013.01)] 38 Claims
 
1. A microbial oil/lipid comprising dihomo-γ-linolenic acid and at least one of C24:0, C22:0, and C20:0 as constituent fatty acids, wherein the microbial oil/lipid comprises (i) dihomo-γ-linolenic acid in a content of greater than 30 wt. %, greater than 32 wt. %, or greater than 34 wt. %; (ii) C24:0, C22:0, and C20:0, in a total content of 12.0 wt. % or less, 11.0 wt. % or less, 10.0 wt. % or less, 9.0 wt. % or less, or 8.0 wt. % or less; and (iii) substantially no arachidonic acid or arachidonic acid in a content of 0.3 wt. % or less, 0.2 wt. % or less, 0.1 wt. % or less, 0.05 wt. % or less, 0.04 wt. % or less, 0.03 wt. % or less, or 0.01 wt. % or less, wherein the microbial oil/lipid comprises no Δ5 desaturase inhibitor.